GH Research | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(12.9%),Peter Kolchinsky(12.9%), etc.
GH Research | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lynx1 Capital Management LP(8.1%),Weston Nichols(8.1%)
GH Research | 6-K: Report of foreign private issuer (related to financial reporting)
GH Research | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
GH Research | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
GH Research | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
GH Research | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
GH Research | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
GH Research | 6-K: Report of foreign private issuer (related to financial reporting)
GH Research | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
GH Research | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
GH Research | 6-K: Report of foreign private issuer (related to financial reporting)
GH Research | 6-K: Report of foreign private issuer (related to financial reporting)
GH Research | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
GH Research | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
GH Research | 20-F: FY2023 Annual Report
GH Research | 6-K: Report of foreign private issuer (related to financial reporting)
GH Research | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lynx1 Capital Management LP(5.8%),Weston Nichols(5.8%)
GH Research | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners II, L.P.(2.5%),VHCP Co-Investment Holdings II, LLC(2.5%), etc.
GH Research | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(10.7%),Peter Kolchinsky(10.7%), etc.
No Data
No Data